Case Shows European Luxury Brands Must Be Popular In Japan To Be Protected There 29/09/2017 by Guest contributor for Intellectual Property Watch Leave a Comment In a recent decision, the Opposition Board of the Japan Patent Office dismissed an opposition filed by CFUB Sisley, a French producer of cosmetics and fragrances founded in 1976, against the word mark “SISLOY” written in a standard character. The case shows that the status of European luxury brand will not automatically enjoy broader scope of protection in Japan unless the brand obtains a high degree of popularity and reputation among Japanese consumers, writes Masaki Mikami.
Use Competition Law For Wider Access To Cheap Medicines? 27/09/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The topic of access to medicines has gained momentum in recent years as high prices of new medicines affect developing countries and developed countries. The role of competition legislation in preventing market abuses and monopoly situations has been pointed to as a possible lever to facilitate access to generic medicines and balance the potential negative effects of intellectual property protection.
UN Technology Bank To Build IP Infrastructure In LDCs; Private Sector Funds Needed 27/09/2017 by William New, Intellectual Property Watch 1 Comment NEW YORK — A new United Nations Technology Bank for least-developed countries aimed at growing technology transfer and intellectual property infrastructure across the 48 poorest nations became operational at last week’s annual UN General Assembly in New York. The bank’s creation represents the first target of the 2030 UN Sustainable Development Goals to be achieved.
Panel Advances Key Public Interest Issues In Gene Editing Technology 21/09/2017 by William New, Intellectual Property Watch 1 Comment WASHINGTON, DC — The still-emerging breakthrough CRISPR gene editing tool has the potential to transform the field and do enormous good for humankind. But let’s make sure we understand it better and ensure the public interest before launching into using it too widely. Meanwhile, companies and researchers are actively licensing the technology. That was a message of a set of panellists working close to CRISPR’s development, speaking at a recent event in Washington, DC.
WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 by Intellectual Property Watch Leave a Comment A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […]
WIPO Committee Unable To Agree Program And Budget After Proposal For Reform 18/09/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Discussions last week at the World Intellectual Property Organization on how international IP systems managed by the organisation are financed have introduced broader questions about core functioning. The WIPO budget for 2018/2019 was not approved in committee during the week, despite efforts by a small group of countries to find common language on changes to the financing of WIPO systems. A number of countries found the proposed changes in the financing of those different systems require deeper analysis on potential consequences, and asked for more time to consult with their capitals.
USTR Launches Review Of IP In Thailand After Reported Improvements On Enforcement 16/09/2017 by William New, Intellectual Property Watch Leave a Comment The Office of the United States Trade Representative (USTR) today announced an “out-of-cycle” review of Thailand’s intellectual property policies after what USTR said were reports of improvement on several IP issues including trademarks and enforcement. Another area of the review will be pharmaceuticals.
Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 by Catherine Saez, Intellectual Property Watch 6 Comments A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated]
The Many Layers Of Best Practices In The Fight Against Counterfeiting, Piracy 14/09/2017 by Peter Kenny for Intellectual Property Watch Leave a Comment Landlocked Switzerland never had to face pirates in seafaring days, but these days Stop Piracy – the Bern-based Swiss anti-counterfeiting and piracy platform – is actively united in fighting this 21st century threat that lurks in cyberspace everywhere. At a recent conference in Neuchâtel, a range of experts, including from the European Union IP Office, explored the issues.
New WIPO External Offices: Candidates At The Door, But What’s In It For WIPO? 13/09/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment For the last two years, World Intellectual Property Organization delegates have been trying to tackle a seemingly unsolvable equation: too many candidate countries for four new WIPO external offices. Yet more time seems necessary to reduce the number of candidates, which show no sign of stepping down, insisting on the value of a WIPO external office. However, some doubts have begun to arise over the benefits of the expansion of WIPO’s network of field offices.